A pilot comparison of helium dilution and plethysmographic lung volumes to assess the impact of a long-acting bronchodilator on lung hyperinflation in COPD

Pulmonary Pharmacology and Therapeutics

Volumn 22, Issue 6, 2009, Pages 522-525

  Cazzola, Mario ^a   Rogliani, Paola ^a   Curradi, Giacomo ^a   Segreti, Andrea ^a   Ciaprini, Chiara ^a   Pezzuto, Gabriella ^a   Saltini, Cesare ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Body plethysmography; Chronic obstructive pulmonary disease; Helium dilution; Lung hyperinflation; Methods for measuring TLC, RV and FRC; Tiotropium

Indexed keywords

HELIUM; TIOTROPIUM BROMIDE;

AGED; ARTICLE; BODY PLETHYSMOGRAPHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERINFLATION; INTERMETHOD COMPARISON; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL; TOTAL LUNG CAPACITY;

AGED; BRONCHODILATOR AGENTS; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; HELIUM; HUMANS; LUNG VOLUME MEASUREMENTS; MALE; PILOT PROJECTS; PLETHYSMOGRAPHY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SCOPOLAMINE DERIVATIVES; TOTAL LUNG CAPACITY;

EID: 71249112715     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2009.05.005     Document Type: Article

References (17)

1. Rodarte J.R., Noredin G., Miller C., Brusasco V., and Pellegrino R. Lung elastic recoil during breathing at increased lung volume. J Appl Physiol 87 (1999) 1491-1495
2. O'Donnell D.E. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 3 (2006) 180-184
3. O'Donnell D.E., and Laveneziana P. Lung hyperinflation in COPD: the impact of pharmacotherapy. Eur Respir Rev 15 (2006) 85-89
4. Cazzola M., MacNee W., Martinez F.J., Rabe K.F., Franciosi L.G., Barnes P.J., et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 31 (2008) 416-469
5. Wanger J., Clausen J.L., Coates A., Pedersen O.F., Brusasco V., Burgos F., et al. Standardisation of the measurement of lung volumes. Eur Respir J 26 (2005) 511-522
6. Baum G.L., Crapo J.D., Celli B.R., and Karlinsky J.B. Textbook of pulmonary disease (1998), Lippincott-Raven Publisher, Philadelphia
7. Garcia J.G., Hunninghake G.W., and Nugent K.M. Thoracic gas volume measurement. Increased variability in patients with obstructive ventilatory defects. Chest 85 (1984) 272-275
8. Mitchell M.M., and Renzetti Jr. A.D. Evaluation of a single breath method of measuring total lung capacity. Am Rev Respir Dis 97 (1968) 571-580
9. Celli B.R., and MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 (2004) 932-946
10. Miller M.R., Crapo R., Hankinson J., Brusasco V., Burgos F., Casaburi R., et al. General considerations for lung function testing. Eur Respir J 26 (2005) 153-161
11. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., et al. Standardisation of spirometry. Eur Respir J 26 (2005) 319-338
12. Di Marco F., Milic-Emili J., Boveri B., Carlucci P., Santus P., Casanova F., et al. Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD. Eur Respir J 21 (2003) 86-94
13. Calverley P.M., Lee A., Towse L., van Noord J., Witek T.J., and Kelsen S. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease. Thorax 58 (2003) 855-860
14. Celli B., ZuWallack R., Wang S., and Kesten S. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest 124 (2003) 1743-1748
15. O'Donnell D.E., Flüge T., Gerken F., Hamilton A., Webb K., Aguilaniu B., et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 23 (2004) 832-840
16. Ferguson G.T. Why does the lung hyperinflate?. Proc Am Thorac Soc 3 (2006) 176-179
17. Maltais F., Hamilton A., Marciniuk D., Hernandez P., Sciurba F.C., Richter K., et al. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest 128 (2005) 1168-1178